| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 1916 | FDHT precursor |
Please inquire for customized filling and bulk quantities.
|
|
Precursor for [18F]FDHT
(16β-[18F]fluoro-5α-dihydrotestosterone) |
||
| Molar Mass: 480.54 | ||
| C22H31F3O6S | ||
| [141664-05-3] | ||
| Colourless solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H NMR spectrum |
||
|
Chemical Name: CA index name: Androstane-3,17-dione, 16-[[(trifluoromethyl)sulfonyl]oxy]-, cyclic 3-(1,2-ethanediyl acetal), (5α,16α)- |
||
|
Synonymes: 16α-[[(trifluoromethyl)sulfonyl]oxy]-3,3-(ethylenedioxy)androstan-17-one; [18F]FDHT precursor |
||
|
Literature: Liu A. et al. Fluorine-18-Labeled Androgens: Radiochemical Synthesis and Tissue Distribution Studies on Six fluorine-Substituted Androgens, Potential Imaging Agents for Prostatic Cancer. J. Nucl. Med 1992, 33, 724-734. |
||
| Liu A. et al. Fluorine-18-Labeled Androgens: Radiochemical Synthesis and Tissue Distribution Studies on Six fluorine-Substituted Androgens, Potential Imaging Agents for Prostatic Cancer. J. Nucl. Med 1992, 33, 724-734. | ||
| Zhou D. et al. Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16α-[18F]fluoroestradiol (FES), [18F]fluoro furanylnorprogesterone (FFNP), and 16beta-[18F]fluoro-5α-dihydrotestosterone (FDHT)as radiopharmaceuticals. J. Label. Compd. Radiopharm. 2014, 5, 371-377 DOI: 10.1002/jlcr.3191 | ||
| Dehdashti F. et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur. J. Nucl. Med. Mol. Imaging 2005, 32, 344-350. | ||
| date of product catalogue issue: 10 May 2017 | ||